MedPath

Effectiveness of giving Transcranial Direct Current Stimulation Primed Intermittent Theta Burst Stimulation over the cerebellum in patients of Treatment Resistant Schizophrenia

Not Applicable
Conditions
Health Condition 1: F20- Schizophrenia
Registration Number
CTRI/2024/02/062629
Lead Sponsor
Shri Guru Ram Rai Institute of Medical and Health Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients with a diagnosis of Schizophrenia based on diagnostic criteria of Diagnostic and Statistical Manual of Mental Disorder, 5th edition

2. Patients aged 18-59 years

3. Patients giving written consent to participate in protocol

4. Patients fulfilling criteria of Treatment resistant schizophrenia according to Modified Kane’s criteria

Exclusion Criteria

1. Patient is uncooperative for procedure

2. Active substance use disorder(except caffeine and tobacco) or any other current psychiatric comorbidity

3. Implanted metal or cerebral devices in head and neck

4. History of unprovoked seizures, intracranial neoplasms or intracranial surgery, or history of severe head injury or cerebrovascular disease

5. Patients having significant unstable medical condition like uncontrolled hypertension, complicated diabetes mellitus, etc

6. Patients receiving ECT in last 6 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess and compare symptoms of schizophrenia in patients of treatment resistant schizophrenia following high definition transcranial direct current stimulation primed intensive cerebellar intermittent theta burst stimulation in active and sham groupTimepoint: Baseline PANSS, BPRS, SCoRS, SAS and CGI will be applied on day 0, 7 and 14
Secondary Outcome Measures
NameTimeMethod
To assess cognitionTimepoint: SCoRS applied on day 0,7 and 14
© Copyright 2025. All Rights Reserved by MedPath